Literature DB >> 12736220

Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development.

Sanja Ivkovic1, Byeong S Yoon, Steven N Popoff, Fayez F Safadi, Diana E Libuda, Robert C Stephenson, Aaron Daluiski, Karen M Lyons.   

Abstract

Coordinated production and remodeling of the extracellular matrix is essential during development. It is of particular importance for skeletogenesis, as the ability of cartilage and bone to provide structural support is determined by the composition and organization of the extracellular matrix. Connective tissue growth factor (CTGF, CCN2) is a secreted protein containing several domains that mediate interactions with growth factors, integrins and extracellular matrix components. A role for CTGF in extracellular matrix production is suggested by its ability to mediate collagen deposition during wound healing. CTGF also induces neovascularization in vitro, suggesting a role in angiogenesis in vivo. To test whether CTGF is required for extracellular matrix remodeling and/or angiogenesis during development, we examined the pattern of Ctgf expression and generated Ctgf-deficient mice. Ctgf is expressed in a variety of tissues in midgestation embryos, with highest levels in vascular tissues and maturing chondrocytes. We confirmed that CTGF is a crucial regulator of cartilage extracellular matrix remodeling by generating Ctgf(-/-) mice. Ctgf deficiency leads to skeletal dysmorphisms as a result of impaired chondrocyte proliferation and extracellular matrix composition within the hypertrophic zone. Decreased expression of specific extracellular matrix components and matrix metalloproteinases suggests that matrix remodeling within the hypertrophic zones in Ctgf mutants is defective. The mutant phenotype also revealed a role for Ctgf in growth plate angiogenesis. Hypertrophic zones of Ctgf mutant growth plates are expanded, and endochondral ossification is impaired. These defects are linked to decreased expression of vascular endothelial growth factor (VEGF) in the hypertrophic zones of Ctgf mutants. These results demonstrate that CTGF is important for cell proliferation and matrix remodeling during chondrogenesis, and is a key regulator coupling extracellular matrix remodeling to angiogenesis at the growth plate.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12736220      PMCID: PMC3360973          DOI: 10.1242/dev.00505

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  62 in total

Review 1.  How matrix metalloproteinases regulate cell behavior.

Authors:  M D Sternlicht; Z Werb
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

2.  The angiogenic factor Cyr61 activates a genetic program for wound healing in human skin fibroblasts.

Authors:  C C Chen; F E Mo; L F Lau
Journal:  J Biol Chem       Date:  2001-10-02       Impact factor: 5.157

3.  Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.

Authors:  Isao Inoki; Takayuki Shiomi; Gakuji Hashimoto; Hiroyuki Enomoto; Hiroyuki Nakamura; Ken-ichi Makino; Eiji Ikeda; Shigeo Takata; Ken-ichi Kobayashi; Yasunori Okada
Journal:  FASEB J       Date:  2001-12-14       Impact factor: 5.191

4.  Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival.

Authors:  E Schipani; H E Ryan; S Didrickson; T Kobayashi; M Knight; R S Johnson
Journal:  Genes Dev       Date:  2001-11-01       Impact factor: 11.361

Review 5.  Transforming growth factor-beta and connective tissue growth factor: key cytokines in scleroderma pathogenesis.

Authors:  C P Denton; D J Abraham
Journal:  Curr Opin Rheumatol       Date:  2001-11       Impact factor: 5.006

6.  Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression.

Authors:  T Sánchez-Elsner; L M Botella; B Velasco; A Corbí; L Attisano; C Bernabéu
Journal:  J Biol Chem       Date:  2001-08-02       Impact factor: 5.157

7.  The low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor is a receptor for connective tissue growth factor.

Authors:  P R Segarini; J E Nesbitt; D Li; L G Hays; J R Yates; D F Carmichael
Journal:  J Biol Chem       Date:  2001-08-22       Impact factor: 5.157

8.  Increased MMP-2 expression in connective tissue growth factor over-expression vascular smooth muscle cells.

Authors:  Wen-Hua Fan; Morris J Karnovsky
Journal:  J Biol Chem       Date:  2001-12-28       Impact factor: 5.157

9.  Genetic manipulation of hedgehog signaling in the endochondral skeleton reveals a direct role in the regulation of chondrocyte proliferation.

Authors:  F Long; X M Zhang; S Karp; Y Yang; A P McMahon
Journal:  Development       Date:  2001-12       Impact factor: 6.868

10.  Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis.

Authors:  Elazar Zelzer; William McLean; Yin-Shan Ng; Naomi Fukai; Anthony M Reginato; Stephanie Lovejoy; Patricia A D'Amore; Bjorn R Olsen
Journal:  Development       Date:  2002-04       Impact factor: 6.868

View more
  281 in total

1.  Connective tissue growth factor is required for skeletal development and postnatal skeletal homeostasis in male mice.

Authors:  Ernesto Canalis; Stefano Zanotti; Wesley G Beamer; Aris N Economides; Anna Smerdel-Ramoya
Journal:  Endocrinology       Date:  2010-06-09       Impact factor: 4.736

2.  The time has come to target connective tissue growth factor in diabetic complications.

Authors:  S M Twigg; M E Cooper
Journal:  Diabetologia       Date:  2004-05-28       Impact factor: 10.122

Review 3.  Matrix remodeling during endochondral ossification.

Authors:  Nathalie Ortega; Danielle J Behonick; Zena Werb
Journal:  Trends Cell Biol       Date:  2004-02       Impact factor: 20.808

4.  De novo characterization of the antler tip of Chinese Sika deer transcriptome and analysis of gene expression related to rapid growth.

Authors:  Baojin Yao; Yu Zhao; Qun Wang; Mei Zhang; Meichen Liu; Hailong Liu; Juan Li
Journal:  Mol Cell Biochem       Date:  2011-12-25       Impact factor: 3.396

Review 5.  Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets.

Authors:  Joon-Il Jun; Lester F Lau
Journal:  Nat Rev Drug Discov       Date:  2011-12-01       Impact factor: 84.694

Review 6.  The role of connective tissue growth factor (CTGF/CCN2) in skeletogenesis.

Authors:  John A Arnott; Alex G Lambi; Christina Mundy; Honey Hendesi; Robin A Pixley; Thomas A Owen; Fayez F Safadi; Steven N Popoff
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2011       Impact factor: 1.807

Review 7.  The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis.

Authors:  Guo-Wei Zuo; Christopher D Kohls; Bai-Cheng He; Liang Chen; Wenli Zhang; Qiong Shi; Bing-Qiang Zhang; Quan Kang; Jinyong Luo; Xiaoji Luo; Eric R Wagner; Stephanie H Kim; Farbod Restegar; Rex C Haydon; Zhong-Liang Deng; Hue H Luu; Tong-Chuan He; Qing Luo
Journal:  Histol Histopathol       Date:  2010-06       Impact factor: 2.303

8.  Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells.

Authors:  Yun Lu; J Michael Thomson; Ho Yuen Frank Wong; Scott M Hammond; Brigid L M Hogan
Journal:  Dev Biol       Date:  2007-08-09       Impact factor: 3.582

9.  Correction to: FoxD1-driven CCN2 deletion causes axial skeletal deformities, pulmonary hypoplasia, and neonatal asphyctic death.

Authors:  Lucas L Falke; Nannan He; Susana M Chuva de Sousa Lopes; Roel Broekhuizen; Karen Lyons; Tri Q Nguyen; Roel Goldschmeding
Journal:  J Cell Commun Signal       Date:  2020-03       Impact factor: 5.782

10.  CCN2 as a novel molecule supporting energy metabolism of chondrocytes.

Authors:  Aya Maeda-Uematsu; Satoshi Kubota; Harumi Kawaki; Kazumi Kawata; Yoshiaki Miyake; Takako Hattori; Takashi Nishida; Norifumi Moritani; Karen M Lyons; Seiji Iida; Masaharu Takigawa
Journal:  J Cell Biochem       Date:  2014-05       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.